PER
Click for more information
0.00% 8.7¢ percheron therapeutics limited

Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-596

  1. Uboy
    4,683 Posts.
    lightbulb Created with Sketch. 1086
    clock Created with Sketch.
    16/10/19
    16:12
    Post #: 40913747
    venBio Select Advisor holds $212.7 million of Sarepta stock. ​

    Adage Capital Management holds $182.3 million ​

    These elephants have deep knowledge of the challenges Sarepta faces re FDA efficacy queries.​

    They have large positions in Sarepta they need to protect.​

    No doubt Goolsbee will be key player going forward as the ANP story unfolds.

    .
    Last edited by Uboy: 16/10/19
    ANP Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 21  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.7¢ 8.7¢ 8.7¢ $1.305K 15K

Buyers (Bids)

No. Vol. Price($)
4 433956 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.8¢ 134433 2
View Market Depth
Last trade - 10.06am 24/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.